Premium
Evolvence India Life Sciences Fund, the debut healthcare fund managed by private equity firm InvAscent, has fully exited its nine-year-old investment in Chennai-based Anjan Drug Pvt. Ltd, two people familiar with the development told VCCircle. The healthcare fund exited the drugmaker by selling its minority stake to a Chennai-based privately held ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
